GEODE CAPITAL MANAGEMENT, LLC - IMMUNE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$65,000
-19.8%
447,0680.0%0.00%
Q4 2016$81,000
+20.9%
447,068
+84.2%
0.00%
Q3 2016$67,000
+71.8%
242,723
+142.9%
0.00%
Q2 2016$39,000
-7.1%
99,9190.0%0.00%
Q1 2016$42,000
-42.5%
99,9190.0%0.00%
Q4 2015$73,000
-37.6%
99,9190.0%0.00%
Q3 2015$117,00099,9190.00%
Other shareholders
IMMUNE PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Geduld E E 35,000$66,0000.04%
Ifrah Financial Services, Inc. 20,956$40,0000.02%
Bank Pictet & Cie (Europe) AG 12,900$25,0000.01%
Pine River Capital Management L.P. 250,000$286,0000.00%
Spark Investment Management LLC 13,500$25,0000.00%
A.R.T. Advisors, LLC 10,201$19,0000.00%
CITIGROUP INC 346$1,0000.00%
GOLDMAN SACHS GROUP INC 32,745$62,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 20,000$38,0000.00%
MORGAN STANLEY 126$00.00%
View complete list of IMMUNE PHARMACEUTICALS INC shareholders